Effective delivery of CRISPR/dCas9-SAM for multiplex gene activation based on mesoporous silica nanoparticles for bladder cancer therapy
Acta Biomaterialia · 2025-05 · 197 · 460-475
DOI: 10.1016/j.actbio.2025.03.032 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Biomaterialia, 2025-05. Verfasst von Jinming Xu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310000, China. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Silicon Dioxide, Nanoparticles, CRISPR-Cas Systems. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Science and Technology Program of Zhejiang Province, National Natural Science Foundation of China, Zhejiang Province Natural Science Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310000, China.
- Department of Urology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310000, China. Electronic address: caiming2002@hotmail.com.
- Department of Urology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310000, China. Electronic address: wenjiaming@zju.edu.cn.
- Department of Urology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310000, China. Electronic address: wangbohan@zju.edu.cn.
Förderung
- Science and Technology Program of Zhejiang Province
- National Natural Science Foundation of China
- Zhejiang Province Natural Science Foundation
- China Postdoctoral Science Foundation
Zitieren
APA
Xu, J., Xu, J., Sun, C., He, X., Shu, Y., Huangfu, Q., Meng, L., Liang, Z., Wei, J., Cai, M., Wen, J., & Wang, B. (2025). Effective delivery of CRISPR/dCas9-SAM for multiplex gene activation based on mesoporous silica nanoparticles for bladder cancer therapy. Acta Biomaterialia, 197, 460-475. https://doi.org/10.1016/j.actbio.2025.03.032
Vancouver
Xu J, Xu J, Sun C, He X, Shu Y, Huangfu Q, et al. Effective delivery of CRISPR/dCas9-SAM for multiplex gene activation based on mesoporous silica nanoparticles for bladder cancer therapy. Acta Biomaterialia. 2025;197:460-475. doi:10.1016/j.actbio.2025.03.032
BibTeX
@article{Xu2025,
author = {Xu, Jinming and Xu, Jiaju and Sun, Chengfang and He, Xuhong and Shu, Yichang and Huangfu, Qi and Meng, Longxiyu and Liang, Zhengxin and Wei, Jingchao and Cai, Ming and Wen, Jiaming and Wang, Bohan},
title = {Effective delivery of CRISPR/dCas9-SAM for multiplex gene activation based on mesoporous silica nanoparticles for bladder cancer therapy},
journal = {Acta Biomaterialia},
year = {2025},
volume = {197},
pages = {460--475},
doi = {10.1016/j.actbio.2025.03.032}
}
EUVIMED